Anis Hamid

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Accumulation of copy number alterations and clinical progression across advanced prostate cancer”.

Accumulation of copy number alterations and clinical progression across advanced prostate cancer

Genome Medicine(2022)10.1186/s13073-022-01080-4

N/A

0.889DataRank · unranked

30 citations

Stefanie Friedrich, Chris Brawley, Larissa Mendes, Marina Parry, Adnan Ali +28 more

Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trial

Annals of Oncology(2021)10.1016/j.annonc.2021.06.003

N/A

0.654DataRank · unranked

77 citations

Hsin-Chieh Huang, V. Wang, Yu‐Hui Chen, Felix Y. Feng, Robert B. Den +11 more

Landscape and impact of germline pathogenic variants (PVs) in metastatic hormone sensitive prostate cancer (mHSPC): Ancillary study of E3805 CHAARTED.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5082

N/A

0.165DataRank · unranked

2 citations

Tyler M Chinsky, M Cristian Vergara, Emily Grist, Gerhardt Attard, Eliezer M. Van Allen +3 more

Transcriptome classification of PTEN inactivation to predict survival benefit from docetaxel at start of androgen deprivation therapy (ADT) for metastatic prostate cancer (PC): An ancillary study of the STAMPEDE trials.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.5003

N/A

0.165DataRank · unranked

2 citations

Peter Dutey‐Magni, Marina Parry, Larissa Mendes, Ashwin Sachdeva, J. Proudfoot +15 more

Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer

Annals of Oncology(2023)10.1016/j.annonc.2023.04.515

N/A

0DataRank · unranked

28 citations

Amol C. Shetty, Alex Hakansson, Kim Van der Eecken, Yang Song, Y. Liu +27 more

1616P Circulating tumour DNA (ctDNA) measurements and PET-imaging to evaluate response in a phase Ib trial of metastatic castration-resistant prostate cancer (mCRPC) treated with Lutetium-177-PSMA-617 (LuPSMA) plus pembrolizumab (PRINCE)

Annals of Oncology(2024)10.1016/j.annonc.2024.08.1697

N/A

0DataRank · unranked

3 citations

Emily Kwan, S.W.S. Ng, Anthony M. Joshua, L. Emmett, Megan Crumbaker +15 more

Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers

Cell(2025)10.1016/j.cell.2025.07.042

N/A

0DataRank · unranked

24 citations

Peter Dutey‐Magni, Marina Parry, Larissa Mendes, Ashwin Sachdeva, James A. Proudfoot +42 more

Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestry

Nature Communications(2025)10.1038/s41467-025-63865-6

N/A

0DataRank · unranked

11 citations

Pamela X. Y. Soh, Jue Jiang, Tumisang M. N. Mbeki, Melanie Louw, Daniel Burns +84 more

Impact of baseline serum IL‐8 on metastatic hormone‐sensitive prostate cancer outcomes in the Phase 3 CHAARTED trial (E3805)

The Prostate(2020)10.1002/pros.24074

N/A

0DataRank · unranked

21 citations

Victoria X. Wang, Anis Hamid, Gabriella Santone, Charles G. Drake, Michael A. Carducci +4 more

Causes of evolutionary divergence in prostate cancer.

PubMed(2025)10.48550/arxiv.2503.13189

N/A

0DataRank · unranked

0 citations

Atef Sahli, Valeriia Haberland, Aleksandra Ziuboniewicz, Christopher L. Wirth, G. Steven Bova +50 more

Luminal B subtype as a predictive biomarker of docetaxel benefit for newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC): A correlative study of E3805 CHAARTED.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.162

N/A

0DataRank · unranked

18 citations

Victoria Wang, Yu‐Hui Chen, Felix Y. Feng, Robert B. Den, Gerhardt Attard +10 more

Impact of baseline serum IL-8 on metastatic hormone-sensitive (mHSPC) prostate cancer outcomes in the phase III CHAARTED trial (E3805).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.171

N/A

0DataRank · unranked

1 citations

Victoria Wang, Hidemi S. Yamamoto, Anis Hamid, Charles G. Drake, Michael A. Carducci +4 more

EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer

Nature Cancer(2021)10.1038/s43018-021-00185-w

N/A

0DataRank · unranked

241 citations

Anjali V. Sheahan, Deborah L. Burkhart, Sylvan C. Baca, Nadia Boufaied, Yin Liu +32 more